Found 100 matching trials
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma PHASE2 This study is being done to find out how effective a new treatment strategy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors PHASE1 This study is designed to evaluate the safety and efficacy of QLF31907 comb...
Show More Location
Multiple Locations
Learn More & Join Trial
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma PHASE2 The aim of the study is to determine if intervening with combined local the...
Show More Location
Fudan Universtiy Shanghai Cancer Center
Learn More & Join Trial
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) PHASE3 This study will compare how safe and effective sacituzumab tirumotecan is v...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as carboplatin, irinotecan, and...
Show More Location
University of Miami Sylvester Comprehensive Cancer Center
Learn More & Join Trial
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer PHASE2 There is a need for more effective therapy for patients following surgery f...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Molecularly Tailored Therapy for Pancreas Cancer PHASE2 Patient therapy is tailored according to the molecular profile of the patie...
Show More Location
Georgetown University- Lombardi Comprehensive Cancer Center
Learn More & Join Trial
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma PHASE2 A two-part trial in patients with metastic Ewing's sarcoma. Participants in...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) PHASE3 In this study, participants with advanced or metastatic adenocarcinoma or s...
Show More Location
Multiple Locations
Learn More & Join Trial